{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:49:28Z","timestamp":1789616968201,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300532"],"award-info":[{"award-number":["82300532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H020002"],"award-info":[{"award-number":["LQ22H020002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025HY0128"],"award-info":[{"award-number":["2025HY0128"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Hangzhou Medical College","award":["KYZD2023004"],"award-info":[{"award-number":["KYZD2023004"]}]},{"name":"General scientific research project of Zhejiang Education Department","award":["Y202456747"],"award-info":[{"award-number":["Y202456747"]}]},{"name":"Traditional Chinese Medicine Science and Technology Project of Zhejiang Province","award":["2026ZL0494"],"award-info":[{"award-number":["2026ZL0494"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Diabetic nephropathy (DN) is a major microvascular complication of diabetes and a leading cause of end-stage renal disease. Chronic inflammation plays a pivotal role in the pathogenesis of DN.\n                      <jats:italic>Lycorine<\/jats:italic>\n                      (LY), a complex tetracyclic pyrrolo\n                      <jats:italic>[de]<\/jats:italic>\n                      phenanthridine alkaloid derived from the\n                      <jats:italic>Amaryllidaceae<\/jats:italic>\n                      family, possesses notable anti-inflammatory activity, yet its therapeutic potential in DN remains insufficiently defined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the renoprotective effects of LY both in vivo and in vitro. Streptozotocin (STZ)-induced diabetic mice were treated with LY, and renal function and histopathological alterations were assessed. In vitro, human renal tubular epithelial HK-2 cells were exposed to high glucose plus palmitic acid (HG\u2009+\u2009PA) with or without LY. RNA-seq analysis was performed to identify LY-regulated pathways. Molecular docking, surface plasmon resonance (SPR) assay, and cellular thermal shift assay (CETSA) were used to evaluate the interaction between LY and receptor for advanced glycation end products (RAGE). RAGE siRNA-mediated knockdown was further conducted to determine whether RAGE is required for the protective effects of LY. Activation of the HMGB1\/RAGE\/NF-\u03baB signaling axis and associated inflammatory mediators was analyzed by Western blotting and RT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LY markedly alleviated renal injury in STZ-induced diabetic mice, as evidenced by reduced albuminuria, improved renal function, and attenuated renal fibrosis, apoptosis, oxidative stress, and inflammation. Notably, LY did not significantly alter blood glucose levels or body weight, indicating that its renoprotective effect was independent of glycemic control. In HG\u2009+\u2009PA-treated HK-2 cells, LY significantly suppressed apotosis, oxidative stress, and inflammatory cytokine expression. Mechanistically, RNA-seq analysis identified AGE-RAGE and NF-\u03baB signaling pathways as key pathways modulated by LY. Molecular docking, SPR, and CETSA confirmed that LY directly interacted with RAGE. Moreover, RAGE knockdown largely abolished the additional protective effects of LY, supporting RAGE as a critical molecular target. LY inhibited HMGB1\/RAGE-mediated NF-\u03baB activation, as reflected by reduced HMGB1, RAGE, p-p65, and p-I\u03baB\u03b1 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LY ameliorates diabetic nephropathy without affecting blood glucose levels by directly targeting RAGE and suppressing the HMGB1\/RAGE\/NF-\u03baB signaling axis. These findings identify LY as a potential RAGE-targeting therapeutic candidate for inflammation-driven diabetic kidney injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01469-y","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:50:37Z","timestamp":1784170237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lycorine ameliorates diabetic nephropathy by targeting RAGE and inhibiting the HMGB1\/RAGE\/NF-\u03baB signaling axis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030369","author":"HM Alkreathy","year":"2022","unstructured":"Alkreathy HM, Esmat A. Lycorine ameliorates thioacetamide-induced hepatic fibrosis in rats: emphasis on antioxidant, anti-inflammatory, and STAT3 inhibition effects. Pharmaceuticals. 2022. https:\/\/doi.org\/10.3390\/ph15030369.","journal-title":"Pharmaceuticals"},{"key":"1469_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.kint.2024.09.010","volume":"107","author":"IJ Chiu","year":"2025","unstructured":"Chiu IJ, Ajay AK, Chen CH, Jadhav S, Zhao L, Cao M, et al. Suppression of aldehyde dehydrogenase 2 in kidney proximal tubules contributes to kidney fibrosis through Transforming Growth Factor-beta signaling. Kidney Int. 2025;107:84\u201398.","journal-title":"Kidney Int"},{"key":"1469_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16:377\u201390.","journal-title":"Nat Rev Nephrol"},{"key":"1469_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102619","author":"A Di Sotto","year":"2023","unstructured":"Di Sotto A, Valipour M, Azari A, Di Giacomo S, Irannejad H. Benzoindolizidine alkaloids tylophorine and lycorine and their analogues with antiviral, anti-inflammatory, and anticancer properties: promises and challenges. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11102619.","journal-title":"Biomedicines"},{"key":"1469_CR5","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1093\/cvr\/cvad190","volume":"119","author":"A Elwakiel","year":"2024","unstructured":"Elwakiel A, Mathew A, Isermann B. The role of endoplasmic reticulum-mitochondria-associated membranes in diabetic kidney disease. Cardiovasc Res. 2024;119:2875\u201383.","journal-title":"Cardiovasc Res"},{"key":"1469_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2337\/db24-0121","volume":"74","author":"S Hagiwara","year":"2025","unstructured":"Hagiwara S, Okabe J, Ziemann M, Drew B, Murakoshi M, Sourris KC, et al. MiR-214 and its primary transcript Dnm3os regulate fibrosis and inflammation through RAGE signaling in diabetic kidney disease. Diabetes. 2025;74:1205\u201319.","journal-title":"Diabetes"},{"key":"1469_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108314","volume":"241","author":"Q Hu","year":"2023","unstructured":"Hu Q, Jiang L, Yan Q, Zeng J, Ma X, Zhao Y. A natural products solution to diabetic nephropathy therapy. Pharmacol Ther. 2023;241:108314.","journal-title":"Pharmacol Ther"},{"key":"1469_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2022.05.024","volume":"187","author":"Q Li","year":"2022","unstructured":"Li Q, Liao J, Chen W, Zhang K, Li H, Ma F, et al. NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2\/Gpx4 pathway. Free Radic Biol Med. 2022;187:158\u201370.","journal-title":"Free Radic Biol Med"},{"key":"1469_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105867","volume":"173","author":"Y Li","year":"2021","unstructured":"Li Y, Xu B, Yang J, Wang L, Tan X, Hu X, et al. Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release. Pharmacol Res. 2021;173:105867.","journal-title":"Pharmacol Res"},{"key":"1469_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104884","volume":"158","author":"Q Liang","year":"2020","unstructured":"Liang Q, Cai W, Zhao Y, Xu H, Tang H, Chen D, et al. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. Pharmacol Res. 2020;158:104884.","journal-title":"Pharmacol Res"},{"key":"1469_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.107054","volume":"200","author":"QR Lin","year":"2010","unstructured":"Lin QR, Jia LQ, Lei M, Gao D, Zhang N, Sha L, et al. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatment of diabetes and its complications: an update since 2010. Pharmacol Res. 2010;200:107054.","journal-title":"Pharmacol Res"},{"key":"1469_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41401-021-00721-5","volume":"43","author":"XQ Liu","year":"2022","unstructured":"Liu XQ, Jiang L, Li YY, Huang YB, Hu XR, Zhu W, et al. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease. Acta Pharmacol Sin. 2022;43:96\u2013110.","journal-title":"Acta Pharmacol Sin"},{"key":"1469_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-023-05964-x","volume":"66","author":"V Lyssenko","year":"2023","unstructured":"Lyssenko V, Vaag A. Genetics of diabetes-associated microvascular complications. Diabetologia. 2023;66:1601\u201313.","journal-title":"Diabetologia"},{"key":"1469_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf7084","volume":"13","author":"MB Manigrasso","year":"2021","unstructured":"Manigrasso MB, Rabbani P, Egana-Gorrono L, Quadri N, Frye L, Zhou B, et al. Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice. Sci Transl Med. 2021;13:eabf7084.","journal-title":"Sci Transl Med"},{"key":"1469_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2030","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fernandez C, Marchant V, Donate-Correa J, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2030;103:282\u201396.","journal-title":"Kidney Int"},{"key":"1469_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07396-4","volume":"16","author":"S Sunilkumar","year":"2025","unstructured":"Sunilkumar S, Subrahmanian SM, Yerlikaya EI, Toro AL, Harhaj EW, Kimball SR, et al. REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy. Cell Death Dis. 2025;16:79.","journal-title":"Cell Death Dis"},{"key":"1469_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-022-00481-w","volume":"28","author":"H Tan","year":"2022","unstructured":"Tan H, Chen J, Li Y, Li Y, Zhong Y, Li G, et al. Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF\/Akt\/ERK pathways. Mol Med. 2022;28:58.","journal-title":"Mol Med"},{"key":"1469_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00125-014-3291-z","volume":"57","author":"G Tesch","year":"2014","unstructured":"Tesch G, Sourris KC, Summers SA, McCarthy D, Ward MS, Borg DJ, et al. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes. Diabetologia. 2014;57:1977\u201385.","journal-title":"Diabetologia"},{"key":"1469_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155464","volume":"128","author":"P Tuo","year":"2024","unstructured":"Tuo P, Zhao R, Li N, Yan S, Yang G, Wang C, et al. Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT\/NF-kappaB pathway. Phytomedicine. 2024;128:155464.","journal-title":"Phytomedicine"},{"key":"1469_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248\u201360.","journal-title":"Kidney Int"},{"key":"1469_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00018-024-05433-7","volume":"81","author":"K Wu","year":"2024","unstructured":"Wu K, Zha H, Wu T, Liu H, Peng R, Lin Z, et al. Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFkappaB signaling pathway. Cell Mol Life Sci. 2024;81:408.","journal-title":"Cell Mol Life Sci"},{"key":"1469_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","volume":"171","author":"XQ Wu","year":"2021","unstructured":"Wu XQ, Zhang DD, Wang YN, Tan YQ, Yu XY, Zhao YY. AGE\/RAGE in diabetic kidney disease and ageing kidney. Free Radic Biol Med. 2021;171:260\u201371.","journal-title":"Free Radic Biol Med"},{"key":"1469_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154266","volume":"104","author":"H Xiao","year":"2022","unstructured":"Xiao H, Xu X, Du L, Li X, Zhao H, Wang Z, et al. Lycorine and organ protection: review of its potential effects and molecular mechanisms. Phytomedicine. 2022;104:154266.","journal-title":"Phytomedicine"},{"key":"1469_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414587","volume":"12","author":"C Xuan","year":"2025","unstructured":"Xuan C, Chen D, Zhang S, Li C, Fang Q, Chen D, et al. Isoquercitrin alleviates diabetic nephropathy by inhibiting STAT3 phosphorylation and dimerization. Adv Sci. 2025;12:e2414587.","journal-title":"Adv Sci"},{"key":"1469_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.kint.2025.07.023","volume":"108","author":"R Yang","year":"2025","unstructured":"Yang R, Hou Q, Chen R, Ma Z, Jiang S, Liu Z. Protein UHRF1-mediated dual dysregulation of molecular chaperone GRP78 induces endoplasmic reticulum stress and aggravates diabetic nephropathy. Kidney Int. 2025;108:883\u2013900.","journal-title":"Kidney Int"},{"key":"1469_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175560","volume":"943","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Sun M, Jin Z, Zheng C, Ye H, Weng H. Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney. Eur J Pharmacol. 2023;943:175560.","journal-title":"Eur J Pharmacol"},{"key":"1469_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.01.010","volume":"197","author":"H Zhao","year":"2023","unstructured":"Zhao H, Chen Y, Qian L, Du L, Wu X, Tian Y, et al. Lycorine protects against septic myocardial injury by activating AMPK-related pathways. Free Radic Biol Med. 2023;197:1\u201314.","journal-title":"Free Radic Biol Med"},{"key":"1469_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156046","volume":"135","author":"D Zhu","year":"2024","unstructured":"Zhu D, Ni Y, Chen C, Dong Z, Wang L, Zhang W. Geniposide ameliorates diabetic nephropathy in type 2 diabetic mice by targeting AGEs-RAGE-dependent inflammatory pathway. Phytomedicine. 2024;135:156046.","journal-title":"Phytomedicine"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01469-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01469-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01469-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:50:39Z","timestamp":1784170239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01469-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01469-y","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"193"}}